GIPL Global Innovative Platforms Inc.
Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1837774 · Fiscal year ends 09/30
Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-20.9%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-361.7%
Net margin-361.7%
FCF margin—
EBITDA margin—
Returns
ROE-190.0%
ROA-180.9%
ROIC (approx.)-395.6%
Asset turnover0.50x
Leverage & solvency
Liabilities / assets1.4%
Debt / equity0.00x
Current ratio34.73x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.50x
Accruals ratio-91.3%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-09-30 | FY20242024-09-30 | FY20232023-09-30 | FY20222022-09-30 | FY2021*2021-09-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $0 | $0 | $0 | $0 | $0 |
| R&D expense | $382,832 | $23,376 | — | — | — |
| SG&A expense | $335,419 | $112,821 | $282,786 | $53,816 | $73,273 |
| Operating income | -$718,251 | -$136,197 | -$282,786 | -$53,816 | -$73,273 |
| Pretax income | -$718,251 | -$136,197 | -$282,786 | -$53,816 | -$73,273 |
| Income tax | — | $0 | $0 | $0 | $0 |
| Net income | -$718,251 | -$136,197 | -$282,786 | -$53,816 | -$73,273 |
| EPS (basic) | -0.02 | -0.01 | -0.46 | -0.08 | -0.12 |
| EPS (diluted) | -0.02 | -0.01 | -0.46 | -0.08 | -0.12 |
| Weighted avg. shares (diluted) | 39.37M | 26.63M | 619,085 | 619,085 | 619,085 |
| Balance sheet | |||||
| Cash & equivalents | $17,828 | $15 | $415 | $47,757 | $262 |
| Receivables | $0 | — | — | — | — |
| Current assets | $199,275 | $15 | $415 | $47,757 | $262 |
| PP&E, net | $0 | $0 | $0 | $0 | $0 |
| Intangibles | $0 | — | — | — | — |
| Total assets | $199,275 | $15 | $415 | $47,757 | $262 |
| Current liabilities | $11,609 | $33,153 | $364,368 | $130,471 | $29,160 |
| Short-term debt | $1,500 | — | — | — | — |
| Total liabilities | $11,609 | $33,153 | $364,368 | $130,471 | $29,160 |
| Shareholders' equity | $187,666 | -$33,138 | -$363,953 | -$82,714 | -$28,898 |
| Shares outstanding | 44.48M | 33.75M | 619,085 | 619,085 | 619,085 |
| Cash flow statement | |||||
| Operating cash flow | -$560,740 | -$87,378 | -$234,793 | -$53,620 | $262 |
| Investing cash flow | -$175,448 | $0 | $0 | $0 | $0 |
| Financing cash flow | $754,001 | $86,978 | $187,451 | $101,115 | $0 |
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.